SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-057569
Filing Date
2015-06-30
Accepted
2015-06-30 16:19:27
Documents
2
Period of Report
2015-06-26

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6474
2 POA DOCUMENT poa.txt EX-24.4_592522 3966
  Complete submission text file 0001209191-15-057569.txt   11955
Mailing Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139
Business Address 840 MEMORIAL DRIVE 5TH FLOOR Cambridge MA 02139 617-551-9600
Cerulean Pharma Inc. (Issuer) CIK: 0001401914 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THRESHOLD PHARMACEUTICALS, INC. 170 HARBOR WAY SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address
Parkinson David Ross (Reporting) CIK: 0001451935 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36395 | Film No.: 15961641